IT Pharma attends the SEME congress

IT Pharma attended the SEME 2018 to present its latest news, among which were Prostrolane Inner B and Turtlepin
SEME 2018

Over 2,000 medical experts attended the Spanish aesthetic medicine congress.

CYet another year running, IT Pharma attended the Spanish Aesthetic Medicine Congress, which took place from 22nd to 24th February in Malaga, organised by the Spanish Society of Aesthetic Medicine (SEME). Scientists specialising in aesthetic medicine attended the three-day Congress Fair, which offered speeches, presentations and stands with representatives from Spain’s main brands.

One of the most eagerly-awaited exhibitions was that of Prostrolane Inner B, a product imported by IT Pharma and commercialised by TOV Medical in Spain. The speech was given by Doctor Juan Miguel Pérez Díaz, from the Pérez Díaz Clinic in Alicante. Over a hundred people attended the presentation about one of the most talked about products in the congress.

The Navarran brand also revealed the new Turtlepin medical device, a head that enables the product or solution to be introduced via hollow hypodermic needles.

This congress is a national and international benchmark, which unites over 2,000 participants each year. According to figures released by the organising company, the number of congress members rose by 10% compared to the previous year, demonstrating the healthy outlook of the sector.


Make a comment